Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TAP genes and immunity.

James McCluskey1, Jamie Rossjohn, Anthony W Purcell

  • 1Department of Microbiology and Immunology, The University of Melbourne, Victoria, Australia. jamesm1@unimelb.edu.au

Current Opinion in Immunology
|September 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinguishing Ile/Leu Variant Ligands in the Immunopeptidome Using Hybrid EAD + CID Fragmentation (ExCID).

Analytical chemistry·2026
Same author

Population pharmacokinetics of polymyxin B: an individual participant data meta-analysis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Identification of an immunogenic epitope from RASGRP2 with specificity for HLA-DR15 in multiple sclerosis.

Journal of neuroimmunology·2026
Same author

Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia.

Emerging infectious diseases·2026
Same author

Ellagic acid metabolism as a source of dietary MR1 ligands.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Conserved CD4<sup>+</sup> T cell staphylococcal and streptococcal epitopes enable broad-acting vaccines in mice.

Nature microbiology·2026
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

The transporter associated with antigen processing (TAP) delivers peptides to MHC class I molecules. Human MHC class I polymorphism influences TAP association, affecting viral resistance and peptide loading.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • The transporter associated with antigen processing (TAP) is crucial for presenting peptides to MHC class I molecules.
  • TAP is a target for genetic alterations in tumors and viral inhibitors.
  • TAP function is linked to MHC class I alleles in some species.

Purpose of the Study:

  • To investigate the role of human MHC class I polymorphism in TAP association and peptide loading.
  • To understand how MHC class I variations influence the peptide-loading complex (PLC).
  • To explore the implications of altered TAP-MHC class I interactions for viral resistance.

Main Methods:

  • Analysis of MHC class I polymorphism in humans.
  • Investigation of tapasin-mediated association with TAP.

Related Experiment Videos

  • Characterization of peptide loading within the PLC.
  • Main Results:

    • Human MHC class I polymorphism dictates tapasin-mediated association with TAP.
    • Peptide optimization within the PLC is influenced by MHC class I genotype.
    • MHC class I molecules not complexed with TAP may exhibit increased resistance to viral interference.

    Conclusions:

    • MHC class I polymorphism plays a significant role in regulating TAP function and peptide presentation.
    • Variations in MHC class I-TAP interactions can impact cellular defense against viral pathogens.
    • Understanding these interactions is key to developing targeted therapies for cancer and viral infections.